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gondii infection
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and Isabelle Dimier-Poisson1,2*
Abstract
Background: Toxoplasmosis is one of the most common parasitic infections in humans. It can establish chronic
infection and is characterized by the formation of tissue cysts in the brain. The cysts remain largely quiescent for
the life of the host, but can reactivate and cause life-threatening toxoplasmic encephalitis in immunocompromised
patients, such as those with AIDS, neoplastic diseases and organ transplants. Toll-like receptor (TLR) adaptor MyD88
activation is required for the innate sensing of Toxoplasma gondii. Mice deficient in MyD88 have defective IL-12 and
Th1 effector responses, and are highly susceptible to the acute phase of T. gondii infection. However, the role of
this signaling pathway during cerebral infection is poorly understood and requires examination.
Method: MyD88-deficient mice and control mice were orally infected with T. gondii cysts. Cellular and parasite
infiltration in the peripheral organs and in the brain were determined by histology and immunohistochemistry.
Cytokine levels were determined by ELISA and chemokine mRNA levels were quantified by real-time PCR (qPCR).
Results: Thirteen days after infection, a higher parasite burden was observed but there was no histological change
in the liver, heart, lungs and small intestine of MyD88−/− and MyD88+/+ mice. However, MyD88−/− mice compared
to MyD88+/+ mice were highly susceptible to cerebral infection, displayed high parasite migration to the brain,
severe neuropathological signs of encephalitis and succumbed within 2 weeks of oral infection. Susceptibility was
primarily associated with lower expression of Th1 cytokines, especially IL-12, IFN-γ and TNF-α, significant decrease in
the expression of CCL3, CCL5, CCL7 and CCL19 chemokines, marked defect of CD8+ T cells, and infiltration of
CD11b+ and F4/80+ cells in the brain.
Conclusion: MyD88 is essential for the protection of mice during the cerebral installation of T. gondii infection.
These results establish a role for MyD88 in T cell-mediated control of T. gondii in the central nervous system (CNS).
Keywords: MyD88, innate immunity, Toxoplasma gondii, BALB/c mice, encephalitis
Background
Toxoplasma gondii is a protozoan parasite responsible
for toxoplasmosis, a worldwide disease that infects ap-
proximately one-third of the world’s population. Despite
the development of protective immunity, parasites persist
in latent cyst form in multiple tissues, most prominently
in the brain. In immunocompetent individuals, the
chronic phase is asymptomatic, but leads to toxoplasmic
encephalitis in immunocompromised individuals [1].
During primary acute infection, T. gondii induce a pro-
tective immunity, which is thought to mainly involve a
systemic Th1 cellular immune response, which is focused
on IL-12 secreted by dendritic cells (DCs) and IFN-
gamma production by CD4+ and CD8+ T lymphocytes
[2]. Recent research on the molecular signaling pathways
triggered during the infection of T. gondii have demon-
strated that the adaptor molecule MyD88, recruited after
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Toll-like receptor (TLR) activation by parasite molecules,
is required for the establishment of this protective im-
mune response.
Studies carried out in MyD88−/− mice unambiguously
demonstrate that this adaptor molecule is required to in-
duce a protective immune response against T. gondii in-
fection. The implication of MyD88 during the immune
response against T. gondii was first shown by Scanga
et al. [3]. Using MyD88-deficient C57BL/6 mice infected
intraperitoneally with an avirulent strain of T. gondii,
they demonstrated that MyD88 was essential for the sur-
vival to the acute phase of infection and for early para-
site replication control. Moreover, such mice are unable
to produce IL-12, a major cytokine in the setting of an
efficient Th1 response [3]. More recent work confirmed
these results following infection of the same type of mice
via the oral route. MyD88−/− mice displayed early death
associated with uncontrolled parasite replication. IL-12
response was severely curtailed during oral infection [4].
Taken together, these data suggest that optimal resist-
ance to T. gondii involves responses to MyD88. There is
also evidence that TLR signaling is strongly implicated,
since tachyzoite profilin and glycosylphosphatidylinositol
(GPI) have recently been identified as parasite ligands of
TLR11 and TLR2/4 respectively [5-7].
Once infection progresses to the chronic phase, it is
crucial to determine the implication of MyD88 in the
process to limit parasite replication in the brain. For the
first time, we used MyD88-deficient mice in resistant
BALB/c background in an experimental T. gondii infec-
tion, to assess the role of the TLR adaptor protein
MyD88 for host resistance to T. gondii cerebral infec-
tion. The studies presented here demonstrate that while
MyD88-deficient mice are able to control the early phase
of infection, they were highly susceptible to cerebral in-
fection. This susceptibility is correlated to the brain of
MyD88 KO animals with a significant reduction in the
expression of several inflammatory mediators and in
CD8+ T cells, a significant infiltration of CD11b+ and
F4/80+ cells associated with an increased parasite migra-
tion to and replication in the brain. MyD88 plays an es-
sential role in establishing the protective central nervous
system (CNS) host response during the installation of T.
gondii infection in the brain.
Materials and methods
Mice
MyD88-deficient mice (MyD88−/−), obtained from Dr S
Akira (Research Institute for Microbial Disease, Osaka
University, Japan) were backcrossed 10 times on the
wild-type BALB/c background and bred at the Institute
de Transgénose (CNRS, Orleans, France) under specific
pathogen free (SPR) conditions. Age-matched BALB/c
mice (MyD88+/+) were purchased from Janvier (Saint
Berthevin, France) and used as controls in all experi-
ments. Adult females weighing 20 to 25 g and aged 10
to 12 weeks were orally infected with 80 cysts of the
76 K strain, obtained as described below. In some
experiments, mice were treated each day with sulfadia-
zine in their drinking water (400 mg/l), beginning 4 days
after infection.
The animal experiments complied with the French
Government’s ethical and animal experiment regulations.
Parasites and T. gondii extract
Tachyzoites of the RH strain of T. gondii were harvested
from infected monolayers of human foreskin fibroblast
(HFF) Hs27 (ATCC CRL-1634) and were used as a
source of T. gondii extract [8].
Cysts of the 76 K strain of T. gondii were obtained
from the brains of CBA/J mice that had been orally
infected with 50 cysts 1 month earlier.
Antigen-induced cytokine production in culture
Spleens and mesenteric lymph nodes (MLNs) were har-
vested 13 days after the infection and pressed through a
stainless steel mesh. Single cell suspensions were
obtained by filtration through a nylon mesh to remove
tissue debris. Spleen erythrocytes were lysed by hypo-
tonic shock, single cells of spleen, and MLNs were
resuspended in RPMI 1640 supplemented with 5% FCS,
HEPES (25 mM), L-glutamine (2 mM), sodium pyruvate
(1 mM), β-mercaptoethanol (5 × 10-5 M) and penicillin
(50 U/ml)/streptomycin (50 μg/ml).
Spleen and MLN cells were cultured in 24-well plates
at 106 cells per well, in 1 ml of culture medium, alone or
containing Toxoplasma extract (10 μg/ml) [8]. The
plates were incubated for 4 days in 5% CO2 at 37°C. Cell
culture supernatants were harvested between 24 hours
and 4 days, and kept at −20°C until cytokine ELISA.
Spleen and MLN cell supernatants were tested for IL-
2, IL-4, IL-10, IL-5, IL-13, IFN-γ, IL-12 and nitric oxide
(NO) activities. Cytokine productions were evaluated
using commercial ELISA kits according to the manufac-
turer’s instructions (e-Bioscience, San Diego, CA, USA),
except for IL-12 p40 (DuoSet, R&D Systems, Minneap-
olis, MN, USA). Concentrations were determined by
reference to standard curves constructed with known
amounts of mouse recombinant IL-2, IL-4, IL-10, IL-5,
IL-13 and IFN-γ. The sensitivity limits for the assays
were 3.1 pg/ml for IL-2, 7.8 pg/ml for IL-4, 15.6 pg/ml
for IL-5, and 31.3 pg/ml for IL-10, IL-13, IL-12p 40
and IFN-γ.
To test the presence of pro- and anti-inflammatory
cytokines in the brains of infected animals, brains were
harvested 13 days after infection and homogenized
in 5 ml of RPMI 1640 with a pestle and mortar.
Organs were then centrifuged for 5 minutes at
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10,000 × g and the supernatants were tested for the
presence of IFN-γ, IL-12p 40, IL-10, IL-2 and IL-13
by ELISA, as described above.
The NO production was evaluated using the Griess
method. Briefly, Griess reagents (sulfanimide 1% and
naphtylethylenediamine 0.1%, ratio 1:1; Sigma-Aldrich,
St Louis, MO, USA) were added to the culture superna-
tants. The absorbance was measured at 540 nm. The
NO concentration was determined with a standard curve
established with a 20 nM sodium nitrite solution. The
sensitivity limit was 2 μM.
RNA extraction
MLNs, spleen, liver, heart, lungs, small intestines and
brains were removed from infected and uninfected mice
13 days postinfection. The organs were placed in TRIzol
(Gibco-BRL, Life Technologies, Grand Island, NY, USA)
and were crushed with an ULTRA-TURRAX (IKA,
Staufen, Germany). The samples were centrifuged at
8,000 x g to eliminate debris and then the supernatants
were stored at −80°C until further processing. RNA was
extracted according to the manufacturer’s instructions
until the isopropanol addition step. The mixes were then
added on Qiagen mini columns (Valencia, CA, USA)
and spun for 15 seconds at 8,000 x g. The flow-through
was discarded and the columns were washed. The follow-
ing steps were carried out according to the manufacturer’s
instructions. RNA quality was estimated by agarose gel
electrophoresis using ethidium bromide for staining and
RNA quantification was performed by Nanodrop (Thermo
Fisher Scientific, Courtaboeuf, France) measuring absorb-
ance at 260 nm.
Analyses of inflammatory chemokines and cytokines by
real-time reverse-transcription PCR (qRT-PCR)
Total RNA was reverse transcribed using oligo(dT) primers
and M-MLV reverse transcriptase (Promega, Madison, WI,
USA) according to the manufacturer’s instructions. Synthe-
sized cDNA was then amplified by PCR using Chromo4
apparatus (Bio-Rad, Hercules, CA, USA). Hypoxanthine
phosphoribosyltransferase mRNA levels were used to
normalize RNA quantification. We used various pri-
mers for chemokine (CCL3, CCL5, CCL7, CCL19,
CCL20 and CCL21) [9], cytokine (IL-17 and IL23) [10]
and stage-specific Toxoplasma antigen (tachyzoite
(SAG1) and bradyzoite (BAG1)) [11] mRNA quantifi-
cation. All real-time PCR (qPCR) displayed an effi-
ciency of between 90% and 110%. Diluted cDNA was
combined with primers and iQ SYBR Green Supermix
(Bio-Rad) according to the manufacturer’s recommen-
dations, and real-time assays were run on a Chromo4
(Bio-Rad). The specificity of the qPCR reactions was
assessed by analyzing the melting curves of the pro-
ducts and size verification of the amplicons. The
information was processed to calculate the relative
gene expression values determined according to a
standard curve.
Histology and immunohistochemistry
For CD8α, CD3 and F4/80 fluorescence staining, at day
13 postinfection, brains were removed and embedded in
optimal cutting temperature (OCT) Tissue Tek com-
pound (Miles Scientific, Naperville, IL, USA) before stor-
age at −80°C until use. Frozen sections of the brains
(8 μm thick) were performed with a cryostat (Leica
CM3050S, Leica Microsystems, Buffalo Grove, IL, USA),
fixed in acetone gradient and incubated with primary
antibodies (rat monoclonal antibodies anti-CD8α, anti-
CD3 and F4/80; AbD Serotec, Kidlington, UK) or a
rabbit serum of Toxoplasma infection for 2 hours at
room temperature. Sections were washed several times
in PBS and were then incubated with a donkey anti-rat
IgG Alexa Fluor 594 (Life Technologies) for 1 hour at
37°C or a donkey anti-rabbit FITC (DAKO, Glostrup,
Denmark). Sections were counterstained with Hoechst
nuclear dye, mounted in Vectashield (H1000, Vector La-
boratories, Burlingame, CA, USA) and observed on a
Zeiss fluorescence microscope with Axiovision software
(Zeiss, Göttingen, Germany).
For CD11b fluorescence staining, adjacent coronal
sections of the brains from infected MyD88−/− and
MyD88+/+ mice were stained. Briefly, after deep anesthesia
(sodium pentobarbital, 40 mg/kg, intraperitoneal (i.p.)),
mice were perfused through the heart with 80 ml of saline
followed by 200 ml of 4% paraformaldehyde in 0.1 M PBS
(pH 7.4). Brains were removed, postfixed for 2 hours in
the same fixative and cryoprotected in a 20% sucrose solu-
tion overnight at 4°C. Coronal sections (45 μm thick) were
cut with a cryostat (Leica CM3050S) and collected every
four sections. After a series of washes in 50% ethanol and
3% H2O2, free floating sections were incubated at room
temperature in primary rat anti-mouse CD11b antibody
(clone 5C6, 1:500; AbD Serotec), in 5% normal horse
serum, 0.2% Triton X-100 (Sigma-Aldrich) in PBS. Thirty-
six hours later, sections were washed in 0.1 M PBS, incu-
bated for 2 hours in a biotinylated anti-rat IgG (1:500;
Jackson ImmunoResearch, West Grove, PA, USA) fol-
lowed by ABC Kit (1:100, 1 hour; Vector Laboratories)
and reacted with 3,3’-diaminobenzidine (DAB; Sigma-
Aldrich) in the presence of H2O2. Sections were rinsed,
mounted on gelatinized glass slides, dehydrated, cleared in
Claral and coverslipped with Eukitt (Sigma-Aldrich).
Cyst counts in the brain
Thirteen days after infection, brains were harvested from
surviving mice and homogenized in 5 ml of RPMI 1640
with a pestle and mortar. The cysts in each brain hom-
ogenate were counted under a microscope (10 counts,
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each on 10 μl). The results are expressed as means ±
standard error of the mean (SEM) for each group.
Real-time PCR (qPCR) in the brain to assess parasite load
A total of 1 μg genomic DNA was prepared from the
brain using a DNeasy tissue kit (Qiagen) according to
the manufacturer’s instructions. Parasite burden was
measured by amplifying the T. gondii B1 gene using the
2 × SYBR Green PCR Master Mix (Life Technologies) on
an iCycler (Bio-Rad).
The primers used for QB1 were: forward, 50-GGAACT
GCATCCGTTCATGAG-30; reverse, 50-TCTTTAAAGCG
TTCGTGGTC-30. A standard curve for parasite equivalents
was generated using a plasmid, as described previously [12].
Statistical analysis
Statistical analysis was performed using the Mann–Whitney
U test (GraphPad Prism software, La Jolla, CA, USA) to
analyze the observed differences in cytokines, chemokines
and cyst counts. A P value <0.05 was considered significant.
Results
MyD88−/− BALB/c mice are highly susceptible to cerebral
T. gondii infection
To evaluate the contribution of MyD88 signaling in the
induction of protective immune response against T. gondii
on genetically resistant BALB/c background, MyD88+/+
and MyD88−/− BALB/c mice were orally infected with 80
cysts of the 76 K strain of T. gondii. Their survival was
monitored over 30 days and they were weighed on a daily
basis over the experimental time course as an indicator of
morbidity. From day 9 to 17, infected MyD88−/− mice
showed greater weight loss than MyD88+/+ mice
(Figure 1A), and displayed other severe symptoms includ-
ing persistent hunched posture, unresponsiveness to
provocation and lack of interaction with littermates. A de-
crease in autonomic nervous system function of infected
MyD88−/− mice, measured by increased urination and
defecation, was also statistically significant when com-
pared to infected MyD88+/+ mice (data not shown).
Within 17 days of infection, while MyD88+/+ mice survive,
all MyD88−/− mice succumb (Figure 1B), presenting signs
of neurotoxoplasmosis characterized by a tilted head to
one side and circling in the cage (Figure 1C), whereas
MyD88+/+ mice did not show any clinical symptoms.
Taken together, these results indicated that the suscepti-
bility of MyD88−/− BALB/c mice was due to an increased
infectivity in the brain. To confirm this hypothesis, and
since mortality during acute T. gondii infection can result
from either uncontrolled inflammation [13] or increased
parasite replication [14,15], we assessed parasite burden in
different organs (small intestine, liver, heart, lungs and
brain), and analyzed immune response in the spleen,
MLNs and brain.
Mesenteric lymph nodes (MLNs) from MyD88−/− mice
show impaired cellular response
To determine why MyD88−/− mice exhibited a pro-
found deficiency in their ability to control Toxoplasma
brain infection, mucosal immune responses were ana-
lyzed in MLNs.
Thirteen days postinfection, MLNs of the sacrificed mice
were removed for cellular analyses. MLNs from MyD88+/+
mice appeared macroscopically to have a classical size
and morphology, whereas MLNs from the MyD88−/− mice
were enlarged with a granular surface (Figure 2A). How-
ever, no difference in cell numbers of MLNs was observed
between the MyD88+/+ and MyD88−/− mice (data not
shown). Since secretion of chemokines is responsible
for the inflammatory cell trafficking toward the sites of
infection and the recruitment of immune cells, such
as macrophages, dendritic cells and neutrophils, we mea-
sured mRNA levels of various chemokines such as CCL3,
CCL5, CCL7, CCL19, CCL20, CCL21, by real-time re-
verse-transcription PCR (qRT-PCR) analysis. Except for
CCL7, there was no upregulation of mRNA expression
of chemokines after infection in both MyD88−/− and
MyD88+/+ mice (Figure 2B).
MyD88 signaling has been reported to be required for
the production of certain cytokines by innate immune
cells such as DCs, macrophages and neutrophils. There-
fore, we then stimulated the MLN cells with T. gondii
protein extract, and evaluated the cytokine (IFN-γ, IL-12,
IL-2, IL-4, IL-5, IL13 and IL-10) and NO production in
the culture supernatants. The IFN-γ, IL-12, IL-2 and IL-10
secretions were dramatically diminished in MyD88−/−
mice compared to the MyD88+/+ animals: 37 and
3059 pg/ml of IFN-γ respectively (P <0.05), 20 and
296 pg/ml of IL-12 (P <0.05), 9 and 17 pg/ml of IL-2
(P <0.05), and 3 and 287 pg/ml of IL-10 (P <0.05)
(Figure 2C). NO levels were not significantly different be-
tween MyD88−/− and MyD88+/+ mice (0.8 and 0.4 μM re-
spectively). The presence of IL-4, IL-5 and IL13 could not
be detected in the supernatants (data not shown).
In the intestinal compartment, MLNs of MyD88−/−
mice showed an absence of efficient cytokine response
against T. gondii 13 days postinfection.
Spleens from MyD88−/− mice show impaired cytokine
response
Thirteen days after infection, MyD88−/− and MyD88+/+
mice were sacrificed, and their spleens were removed for
cellular analysis. Macroscopically, spleens from MyD88−/−
mice failed to display the splenomegaly observed in
infected MyD88+/+ controls (Figure 3A), suggesting an
impaired immune response in those mice. To characterize
the immune response in the spleens of T. gondii-infected
BALB/c MyD88+/+ and MyD88−/− mice, mRNA levels
of chemokines were measured by qRT-PCR analysis.
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Thirteen days after infection, mRNA expression of CCL3
and CCL7 in the spleens of MyD88−/− was increased by
approximately 21 and 61 fold respectively over non-
infected MyD88−/−. These over-expressions were signifi-
cantly higher than those observed in MyD88+/+ mice
(Figure 3B). Conversely, there was no significant increase
in mRNA expression of CCL5, CCL19, CCL20 and
CCL21 chemokines after infection in both MyD88+/+ and
MyD88−/− mice (Figure 3B). As in MLN cells, cytokine
production and NO synthesis were measured in the super-
natant of T. gondii-extract-stimulated-splenocytes. Cyto-
kines such as IL-17 and IL-23 were analyzed by qRT-PCR.
No significant difference was observed between the two
genotypes (data not shown). The production of IFN-γ,
IL-12, IL-2, IL-10 and NO was dramatically decreased in
MyD88−/− mice compared to their wild-type counter-
parts: 54 and 3404 pg/ml of IFN-γ respectively (P <0.05),
32 and 408 pg/ml of IL-12 (P <0.05), 1 and 31 pg/ml of
IL-2 (P <0.05), 11 and 278 pg/ml of IL-10 (P <0.05), and
0.5 and 7 pg/ml of NO (P <0.05) (Figure 3C). We could
not find any significant level of IL-4, IL-5 and IL-13 in
the supernatants of the cultured spleen cells from either
MyD88+/+ or MyD88−/− mice. These results suggest a
dramatic reduction of innate and adaptive immune
responses in the spleens of mice deficient in MyD88
adaptor molecule.
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Figure 1 MyD88−/− BALB/c mice are highly susceptible to oral infection with T. gondii. (A) Loss of weight after oral infection with 80
cysts of the 76 K T. gondii strain. The total number of tested animals in each group is n = 7. This result is representative of three
independent experiments. (B) Survival after oral infection with 80 cysts of the 76 K T. gondii strain. Data are expressed as percentage of
cumulative survival during the experiment. The total number of tested animals in each group is n = 7. This result is representative of three
independent experiments. (C) Picture of a MyD88−/− BALB/c mouse with neurotoxoplasmosis symptoms at 13 days postinfection displaying
a tilted position. (D) Expression of bradyzoite (BAG1) and tachyzoite (SAG1) mRNA in the lungs, heart, liver and small intestine of MyD88−/−
and MyD88+/+ BALB/c mice 13 days postinfection. The results are presented as a ratio of the expression level in MyD88−/− mice on the
expression in MyD88+/+ mice. Results are representative of two different experiments. The total number of tested animals in each group
are n = 7. (E) Survival after oral infection with 80 cysts of the 76 K T. gondii strain of sulfadiazine-treated mice. Mice were treated with
sulfadiazine beginning 4 days after infection. The total number of tested animals in each group is n = 6. This result is representative of
two independent experiments.
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Higher parasite burden but no histological change in
peripheral organs of MyD88−/− mice compared to
MyD88+/+ mice
Using qPCR, the mRNA levels of BAG1 and SAG1 were
measured to analyze the replication of tachyzoites and
bradyzoites in the liver, lungs, heart and small intestine.
We observed a moderate increase in the expression of
SAG1 in the liver and the small intestine (approximately
13 and 16 fold respectively), but an important increase
in the heart and lungs of MyD88−/− mice infected with
T. gondii compared to MyD88+/+ mice (68 and 195 fold
respectively) (Figure 1D). In addition, bradyzoites were
not detectable in peripheral organs of MyD88+/+ and
MyD88−/− mice, except in the lungs of MyD88−/− mice
(Figure 1D).
After histopathological analysis of these different
organs, we observed that no groups exhibited any path-
ology in the liver and small intestine. Although there
were no significant differences between MyD88+/+ or
MyD88−/− mice, the two groups exhibited limited indica-
tors of pathology with a mild inflammation of the heart
and lungs (data not shown). Moreover, MyD88−/− mice
organs did not have significantly greater extracellular
parasite burden than MyD88+/+ mice organs. In
addition, there were no significant differences in T. gon-
dii-specific IgG1 and IgG2a antibody levels or serum
levels of IL-4, IL-12 or IFN-γ between MyD88+/+ or
MyD88−/− mice (data not shown).
In order to determine if the mortality observed in
infected MyD88−/− mice after the second week of infec-
tion was associated with toxoplasmic myocarditis, pneu-
monia and/or encephalitis, a sulfadiazine treatment was
given to these animals and to MyD88+/+ mice every day
beginning 4 days after infection. Surprisingly, MyD88−/−
mice were unable to establish a chronic infection and all
succumbed during the sulfadiazine treatment from day
13 to day 17 (Figure 1E). Once more, MyD88−/− mice
revealed symptoms of an infection at the cerebral level
with piloelection, huddling, lost of mobility, a tilted head
to one side and circling in the cage, indicating a persist-
ence of tachyzoite proliferation in the brain. In contrast,
control-infected mice did not develop illness and all
survived until the end of the observation period. In
MyD88−/− mice, active infection with tachyzoites appears
to continue in the brain during the entire period of sulfa-
diazin treatment.
These results suggest that the brains of MyD88−/− mice
were highly parasitized by tachyzoite forms of T. gondii.
MyD88−/− mice show increased brain pathology during
infection with T. gondii
Macroscopic observation of brains from MyD88−/− mice
revealed distinct hemorrhagic and necrotic areas, differ-
ing substantially from MyD88+/+ controls (Figure 4A).
MyD88−/− mice had significantly more cysts than
MyD88+/+ mice (1137 versus 65 cysts per brain respect-
ively, P <0.05) (Figure 4B, left graph). Thirteen days after
infection, quantification of parasite DNA in the brain
revealed an increased parasite burden by sevenfold
(40,000 versus 5,700 parasitic burden) (Figure 4B, middle
graph). Moreover, using qPCR the mRNA levels of
BAG1 and SAG1 were measured and analyzed to distin-
guish the replication of tachyzoites and bradyzoites
C
A MyD88+/+ MyD88-/-
B
0 5 10 15
CCL3
CCL5
CCL7
CCL19
CCL20
CCL21
*
MyD88-/-MyD88+/+
Fold change
Infected / non infected
1 cm
0
1000
2000
3000
4000
*
IF
N
- 
pg
/m
l
0
5
10
15
20
*
IL
- 2
 p
g/
m
l
0
100
200
300
400
*
IL
- 1
0 
pg
/m
l
MyD88+/+ MyD88-/-
0
100
200
300
400
*IL
- 1
2p
40
  p
g/
m
l
Figure 2 Impaired mucosal immune response in MyD88−/−mice
infected with T. gondii. (A) Macroscopic observation of MyD88+/+
and MyD88−/− MLNs of mice infected with 80 cysts of the 76 K T.
gondii strain 13 days postinfection. (B) qRT-PCR evaluation of the
expression of chemokine mRNA in MLNs of MyD88+/+ (open bars)
and MyD88−/− (solid bars) BALB/c mice 13 days postinfection.
Results are presented as the fold increase expression of mRNA in
infected mice versus expression of mRNA in non-infected mice. The
results are representative of two experiments with 7 mice per group.
(C) cytokine levels in supernatants of MLN cells restimulated by
Toxoplasma extract from MyD88+/+ and MyD88−/− BALB/c mice
13 days postinfection. Supernatants were collected between 48 and
96 hours to determine cytokines levels (IL-10 at 72 h, IL-2 at 48 h,
IFN-γ at 96 h and IL-12 p40 at 48 h) in MyD88+/+ (open bars) and
MyD88−/− (solid bars) mice. These results are representative of two
independent experiments with 7 mice per group. Data analyzed
using a Mann–Whitney test * (P <0.05). MLN, mesenteric lymph
node; qRT-PCR, real-time reverse-transcription polymerase
chain reaction.
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(Figure 4B, right graph). We observed a strong in-
crease of SAG1 and BAG1 expression in the brains of
MyD88−/− mice infected with T. gondii compared to
MyD88+/+ mice (about 1,800 fold for SAG1 and BAG1).
These results suggest that brains of MyD88−/− mice
were highly parasitized by tachyzoite and bradyzoite
forms of T. gondii.
Toxoplasma immunolabeling indicated that the most
prominent pathology was evident in the brain, with the
presence of a high number of extracellular parasites
13 days postinfection of MyD88−/− mice (Figure 4C).
Using immunohistochemical and histopathological
methods on sections of the brain, we examined the
inflammatory cell responses in the brains of MyD88−/−
and MyD88+/+ mice, by immunostaining for CD11b, F4/
80, CD8α and CD3. In infected MyD88−/− mice, CD11b
labeling showed widespread macrophage/microglial acti-
vation observed all over the brain from the olfactory
bulbs to the brainstem levels. In particular, the immuno-
labeling showed numerous clusters of intensely stained
ameboid microglia, which are illustrated in Figure 4D.
In contrast, ramified microglia are evenly distributed
throughout the brain of infected MyD88+/+ mice with
only very few clustered microglia. No clusters were
observed in non infected MyD88+/+ mice (data not
shown). Immunofluorescence staining with F4/80 gave
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Figure 3 Impaired splenic immune response in MyD88−/−mice infected with T. gondii. (A) Splenomegaly in MyD88−/− but not in MyD88+/+
mice, infected with 80 cysts of the 76 K T. gondii strain 13 days postinfection. (B) Expression of chemokine mRNA in the spleens of MyD88+/+
(open bars) and MyD88−/− (solid bars) BALB/c mice 13 days postinfection, evaluated by qRT-PCR. Results are presented as the fold increase
expression of mRNA in infected mice versus expression of mRNA in non-infected mice. The results are representative of two independent
experiments with 7 mice per group. (C) cytokine and NO production by Toxoplasma extract stimulated spleen cells from MyD88−/− and MyD88+/+
BALB/c mice 13 days postinfection. Supernatants were collected between 24 and 96 hours to determine cytokines levels (IL-10 at 72 hours, IL-2 at
48 hours, IFN-γ at 96 hours, IL-12 p40 at 48 hours and NO at 24 hours) in MyD88+/+ (open bars) and MyD88−/− (solid bars) mice. These results are
representative of two independent experiments. The total number of tested animals in each group is n = 7. Data analyzed using a Mann–Whitney
test * (P <0.05). qRT-PCR, real-time reverse-transcription polymerase chain reaction.
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Figure 4 The particular case of the brain. (A) Macroscopic observation of the brains of MyD88−/− and MyD88+/+ mice infected with 80 cysts of
the 76 K T. gondii strain 13 days postinfection. Brains from MyD88−/− mice revealed distinct hemorrhagic (black arrows) and necrotic areas (white
arrows), differing substantially from MyD88+/+ controls. (B) Thirteen days postinfection, mice from both genotypes were sacrificed and their brains
were removed to analyze parasite loads after brain homogenization by microscopic counting (left graph), by qPCR (middle graph), and by qRT-
PCR to analyze expression of bradyzoite (BAG1) and tachyzoite (SAG1) mRNA (right graph). The results are presented as the ratio of the
expression level in MyD88−/− mice to the expression in MyD88+/+ mice. The data were statistically analyzed using the Mann–Whitney U test
(GraphPad Prism software), * (P <0.05). The results are representative of four independent experiments with n = 7 mice. (C) Immunofluorescence
staining of Toxoplasma gondii tachyzoites in the brain of MyD88−/− mice. Frozen brain sections were stained with a polyclonal rabbit anti-
Toxoplasma, followed by a FITC-conjugated donkey anti-rabbit serum and counterstained with Hoechst to show nuclei. The arrow shows DNA
parasite (x 100). (D) Microglia was stained using a CD11b antibody. (A) to (D): microphotographs of the wild-type MyD88+/+ only showing
ramified microglia and very few clustered ameboid microglia; (E) to (H): microphotographs of MyD88−/− brain sections showing numerous
clustered ameboid and ramified microglia. (A) and (E): striatum and cortex areas; (B) and (F): hippocampal area; (C) and (G): periaqueductal gray
and midbrain areas; (D) and (H): brainstem and cerebellum. The staining was repeated in two other mice in each group with similar staining. Bar
= 500 μm left column, bar = 50 μm right column. FITC, fluorescein isothiocyanate; qPCR, real-time polymerase chain reaction; qRT-PCR, real-time
reverse-transcription polymerase chain reaction.
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similar results as CD11b immunolabeling. In addition,
parasites could be observed on the brain section with
Hoechst stain within F4/80+ cells (Figure 5A).
We observed an increase of CD8α (Figure 5B) and
CD3+ cells (Figure 5C) in MyD88+/+ mice compared to
MyD88−/− mice, suggesting an infiltrate of T lympho-
cytes in the brains of infected MyD88+/+ mice.
It has been shown that chemokines are important in
controlling T. gondii infection and ensuing encephalitis,
in part due to their ability to recruit immune effector
cells to sites of infection. After infection, mRNA tran-
script levels of CCL3, CCL5, CCL7 and CCL19 were sig-
nificantly and consistently increased in the brains of
MyD88+/+ mice compared to the brains of MyD88−/−
C
MyD88 -/-MyD88 +/+
H
oe
ch
st
F4
/8
0
M
er
ge
d
MyD88 -/-MyD88 +/+
H
oe
ch
st
CD
8
M
er
ge
d
A
H
oe
ch
st
CD
3
M
er
ge
d
MyD88 -/-MyD88 +/+
B
D
30 200 400 2000 4000
CCL5
CCL20
CCL21
*
MyD88-/-MyD88+/+
*
*
Fold change
Infected / non infected
0
20
40
60
80
*
TN
F
 
pg
/m
l
E
MyD88+/+ MyD88-/-
0
500
1000
1500
2000
*
IF
N
 
pg
/m
l
0
500
1000
1500
*IL
- 1
2p
40
  p
g/
m
l
*CCL3
CCL7
CCL19
Figure 5 Enhanced neurotoxoplasmosis. Immunofluorescence staining of (A) F4/80, (B) CD8α and (C) CD3+ cells in the brains of MyD88−/−
and MyD88+/+ mice. Frozen brain sections were stained with rat anti-F4/80, rat anti-CD8 and rat anti-CD8, followed by an Alexa 594-conjugated
secondary antibody against rat IgG. Sections were counterstained with Hoechst (x 100). (D) Expression of chemokine mRNA in the brains of
MyD88+/+ (open bars) and MyD88−/− (solid bars) BALB/c mice 13 days postinfection evaluated by qRT-PCR. Results are presented as the fold
increase expression of mRNA in infected mice versus expression of mRNA in non-infected mice. The results are representative of two different
experiments. The total number of tested animals in each group is n = 7. (E) Determination of cytokine levels in supernatants of brain
homogenates from MyD88+/+ and MyD88−/− BALB/c mice 13 days postinfection. Supernatants from MyD88+/+ (open bars) and MyD88−/− (solid
bars) were collected to determine cytokine levels. Results are representative of two experiments and were analyzed using a Mann–Whitney test.
* (P <0.05). qRT-PCR, real-time reverse-transcription polymerase chain reaction.
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mice (about 2,500 fold for CCL3; 1,500 fold for CCL5;
70 fold for CCL7; and 20 fold for CCL19, compared to
non-infected) (Figure 5D). The expression of those tran-
scripts was much lower in MyD88−/− mice. Taken to-
gether, these results showed that the chemokine mRNA
responses in the brains of infected mice were signifi-
cantly different between MyD88−/− and MyD88+/+ mice.
In contrast, transcript levels of CCL20, CCL21 were
detected at similar levels in infected MyD88+/+ and
MyD88−/− mice. There is no increase of mRNA expres-
sion for IL-17 and IL-23 in the brains of infected
MyD88−/− and MyD88+/+ mice (data not shown).
These brains were subsequently homogenized and
pro- and anti-inflammatory cytokines were measured at
the protein level in the supernatants. There was signifi-
cantly less IFN-γ produced in MyD88−/− mice compared
to MyD88+/+ animals: 651 and 1290 pg/ml respectively
(P <0.05) (Figure 5E). The levels of IL-12 and TNF-α
were also significantly increased in the brain during T.
gondii infection in MyD88+/+ compared with MyD88−/−
mice (926 and 185 pg/ml respectively (P <0.05) for IL-
12, and 57 and 37 pg/ml respectively (P <0.05) for TNF-α)
(Figure 5E).
NO levels were not significantly different between
MyD88−/− mice and MyD88+/+ mice (5.6 and 4.1 μM re-
spectively), and IL-13, IL-2 and IL-10 could not be
detected in the supernatants (data not shown). There-
fore, MyD88−/− mice would have less inflammation in
the brain than MyD88+/+ controls.
The data demonstrate highly increased susceptibility
of MyD88−/− mice to Toxoplasma-induced encephalitis,
which is correlated with reduced innate and adaptive im-
mune responses. MyD88−/− mice survive the acute phase
of infection, but succumb as a consequence of the pres-
ence of large numbers of parasites in the brain.
Therefore, MyD88 plays an essential role in host resist-
ance by influencing the control of T. gondii replication.
Discussion
Several in vitro and in vivo studies have shown that
MyD88 is required to control the acute phase of Toxo-
plasma infection and to generate an effective T cell im-
mune response. Currently, there is no evidence that
MyD88 contributes to control the cerebral phase of in-
fection and the MyD88-mediated mechanism controlling
parasite levels in the brain remains to be defined.
We investigated the role of MyD88-dependent innate
immune responses in the regulation of parasite and cell
infiltration into the brain, which are a major pathogenic
event of infection with T. gondii, by using infected BALB/
c mice which develop an acute infection with little sign of
diseases, either control infection and become latently
infected with no clinical symptoms but form cysts in the
brain as occurs in immunocompetent humans.
We report that the absence of MyD88 signaling
impacts host defenses and is essential for protection dur-
ing the acute stage of encephalitis of T. gondii infection
as MyD88−/− mice succumbed to Toxoplasma encephal-
itis. Conversely, no significant pathological differences
were identified in other tissues distinct from the brain
between MyD88−/− mice and MyD88+/+ BALB/c mice
infected with T. gondii, nor was there evidence of altera-
tions in the systemic immune response as measured by
levels of serum cytokines and antigen-specific IgG1 or
IgG2a antibodies. This extreme susceptibility was corre-
lated with an alteration in systemic and mucosal im-
mune responses as measured by: 1) a low Th1 and Th2
cytokine production in the spleen and MLNs compared
to the infected wild-type mice, and 2) a perturbation in
chemokine transcript levels in spleens and MLN com-
partments. In parallel, we observed that Toxoplasma en-
cephalitis, not impacted by sulfadiazine treatment, is
correlated with an increased parasite burden and a lower
expression of Th1-cytokine expression, especially IL-12,
IFN-γ and TNF-α in the brain. Indeed a significant in-
crease of tachyzoite and bradyzoite forms was observed
in the brains of T. gondii-infected MyD88−/− mice and it
is likely that this increase was a result of a defect in an
anti-toxoplasma type-1 response in the brain. It has
already been observed that severe pathology in the
brains of T. gondii-infected mice was correlated with
decreased expression of type-1 mediators. It is highly
probable that the decrease in proinflammatory mediators
observed in the brain of T. gondii-infected MyD88−/− mice
is a direct consequence of a greater parasite burden.
IFN-γ is the major mediator of protective immunity
against T. gondii [16] and is the absolute requirement
for controlling tachyzoites proliferation during the acute
stage of T. gondii infection, and also the central cytokine
in protective immunity to the parasite and type-1 im-
mune responses are vital for survival during infection
[17-19]. The control of T. gondii in the CNS is
dependent on local T cell production of IFN-γ, leading
to the activation of anti-parasitic effector mechanisms.
It has been shown that both T cells [20] and non-T
cells, most likely microglia [21], need to produce IFN-γ
to prevent toxoplasmosis, and that IFN-γ activates
microglia and astrocytes to prevent proliferation of
tachyzoites [22].
We have shown that severe toxoplasmic encephalitis
in T. gondii-infected MyD88−/− mice is associated with a
marked defect in the number of CD8+ T cells, and a sig-
nificantly greater number of CD11b+ and F4/80+ cells
(but no CD11c+ cells) in the brain, and that resistance in
infected wild-type mice is correlated with a greater num-
ber of CD8+ T cells and a low number of antigen-
presenting cells. Therefore, it appears that recruitment
of selected CD8+ T cells is important for the prevention
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of Toxoplasma encephalitis most likely by IFN-γ synthe-
sis. The enhanced parasite replication and associated
local decrease in the number of CD8+ T cells and IFN-γ
production observed in the brains of MyD88−/− are also
noted in mice that lack inducible nitric oxide synthase
(iNOS) and TNF-α signaling [23], IL-33 receptor [24] or
NF-kappaB1 [25]. It also appears that trafficking of
CD11b+ and F4/80+ cells to the brain is correlated to
majoration of encephalitis. It was previously shown that
CD11c- and CD11b+ cells are the major cell population
that disseminates the parasite to the brain, and that
macrophages might be involved in carrying tachyzoites
in the brain after infection [26].
We have also analyzed the production of chemokines
after T. gondii infection at brain level. In contrast to
wild-type mice we detected only low levels of chemokine
mRNA in the brain of infected MyD88−/− mice. Levels
of CCL3, CCL5, CCL7 and CCL19, which are most
abundant in the brain of infected wild-type mice, were
limited in the MyD88−/− mice. Regardless of a direct or
indirect effect, it is clear that MyD88 is crucial for indu-
cing expression of these four chemokines in the brain
during T. gondii infection. However, the importance of
MyD88 in chemokine expression in the brain of mice
during Toxoplasma infection has not been reported be-
fore. It is possible that macrophages and astrocytes pro-
duce these chemokines in the brain, and that a majority
of the cells producing the chemokines in the brains of
infected mice would probably not be those infected by
the parasite. Indeed after activation by IFN-γ, these cells
are able to inhibit the intracellular proliferation of tachy-
zoites [27,28]. In relation to our binding, Wen et al. [29]
have previously reported that CXCL9, CXCL10 and
CCL5 are the chemokines predominantly induced in the
brain of mice during Toxoplasma infection, and their ex-
pression is dependent on IFN-γ. Expression of CCL3,
CCL5, CCL7 and CCL19 chemokines could play a cru-
cial role in recruitment of IFN-γ-producing CD8+ T cells
into the brain, and in facilitating migration of effector
macrophages for prevention of Toxoplasma encephalitis
during acute stage of encephalitis.
In summary, we demonstrate that during infection
MyD88 signaling is essential for the development of an
efficient intracerebral cellular immune response able to
control parasite levels. The results presented here estab-
lish a role for MyD88 in T cell-mediated control of T.
gondii in the CNS.
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